title: Inhibition of erythrocyte phosphatidylserine exposure by urea and Cl-.
abstract: Osmotic shock by addition of sucrose to the medium stimulates erythrocyte sphingomyelinase with subsequent ceramide formation and triggers Ca(2+) entry through stimulation of cation channels. Both ceramide and Ca(2+) activate an erythrocyte scramblase, leading to breakdown of phosphatidylserine asymmetry, a typical feature of apoptosis. Because erythrocytes are regularly exposed to osmotic shock during passage of kidney medulla, the present study explored the influence of NaCl and urea on erythrocyte phosphatidylserine exposure as determined by annexin binding. The percentage of annexin-binding erythrocytes increased from <5 to 80 +/- 4% (n = 4) upon addition of 650 mM sucrose, an effect paralleled by activation of the cation channel and stimulation of ceramide formation. The number of annexin-binding erythrocytes increased only to 18% after addition of 325 mM NaCl and was not increased by addition of 650 mM urea. According to whole cell patch-clamp experiments, the cation conductance was activated by replacement of extracellular Cl(-) with gluconate at isotonic conditions or by addition of hypertonic sucrose or urea. Although stimulating the cation conductance, urea abrogated the annexin binding and concomitant increase of ceramide levels induced by osmotic cell shrinkage. In vitro sphingomyelinase assays demonstrated a direct inhibitory effect of urea on sphingomyelinase activity. Urea did not significantly interfere with annexin binding after addition of ceramide. In conclusion, both Cl(-) and urea blunt erythrocyte phosphatidylserine exposure after osmotic shock. Whereas Cl(-) is effective through inhibition of the cation conductance, urea exerts its effect through inhibition of sphingomyelinase, thus blunting formation of ceramide.
authors.affiliation: Physiologisches Institut, der Universität Tübingen, Gmelinstr. 5, D-72076 Tübingen, Germany.
authors.forename: Karl S
authors.initials: KS
authors.lastname: Lang
authors.forename: Swetlana
authors.initials: S
authors.lastname: Myssina
authors.forename: Philipp A
authors.initials: PA
authors.lastname: Lang
authors.forename: Valerie
authors.initials: V
authors.lastname: Tanneur
authors.forename: Daniela S
authors.initials: DS
authors.lastname: Kempe
authors.forename: Andreas F
authors.initials: AF
authors.lastname: Mack
authors.forename: Stephan M
authors.initials: SM
authors.lastname: Huber
authors.forename: Thomas
authors.initials: T
authors.lastname: Wieder
authors.forename: Florian
authors.initials: F
authors.lastname: Lang
authors.forename: Christophe
authors.initials: C
authors.lastname: Duranton
mesh_terms: D017302:Annexins / Q000378:metabolism; D002518:Ceramides / Q000097:blood; D002712:Chlorides / Q000494:pharmacology*; D004912:Erythrocytes / Q000187:drug effects*; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D006801:Humans; D066298:In Vitro Techniques; D007679:Kidney Medulla / Q000378:metabolism; D009997:Osmotic Pressure / Q000187:drug effects; D018408:Patch-Clamp Techniques; D010718:Phosphatidylserines / Q000097:blood*; D011485:Protein Binding; D012462:Saline Solution, Hypertonic; D013108:Sphingomyelin Phosphodiesterase / Q000737:chemistry; D013210:Staphylococcus / Q000201:enzymology; D013395:Sucrose / Q000494:pharmacology; D014508:Urea / Q000494:pharmacology*
chemical_list: D017302:Annexins; D002518:Ceramides; D002712:Chlorides; D010718:Phosphatidylserines; D012462:Saline Solution, Hypertonic; D013395:Sucrose; D014508:Urea; D013108:Sphingomyelin Phosphodiesterase